Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jan;9(1):3-8.
doi: 10.3892/ol.2014.2696. Epub 2014 Nov 10.

Diagnostic and prognostic serum marker of cholangiocarcinoma (Review)

Xiaojun Zeng  1 , Hualin Tao  2
Affiliations

Diagnostic and prognostic serum marker of cholangiocarcinoma (Review)

Xiaojun Zeng et al. Oncol Lett. 2015 Jan.

Abstract

Cholangiocarcinoma (CCA) is a fatal disease that is typically diagnosed late and treated ineffectively. As the morbidity and mortality rates for CCA rise markedly, patietns with CCA currently have a poor prognosis. However, if it were possible to diagnose CCA early while effective treat methods are available, CCA patients would achieve a better quality of life. Therefore, preventing the process of CCA in the early stages is an urgent problem to solve. An accurate, quick and safe method to diagnose early-stage CCA is required. The present review discusses the risk factors, status of research and certain serum markers of CCA. The sensitivity and specificity of these markers differ from each other. To explore the more accurate serum markers may be a novel direction and method for the diagnosis of CCA in laboratory medicine in the future.

Keywords: cholangiocarcinoma; diagnostic; prognostic; serum marker.

PubMed Disclaimer

References

    1. Khan SA, Davidson BR, Goldin RD, et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update. Gut. 2012;61:1657–1669. doi: 10.1136/gutjnl-2011-301748. - DOI - PubMed
    1. Gentilini A, Rombouts K, Galastri S, et al. Role of the stromal-derived factor-1 (SDF-1)-CXCR4 axis in the interaction between hepatic stellate cells and cholangiocarcinoma. J Hepatol. 2012;57:813–820. doi: 10.1016/j.jhep.2012.06.012. - DOI - PubMed
    1. Limpaiboon T. Epigenetic aberrations in cholangiocarcinoma: potential biomarkers and promising target for novel therapeutic strategies. Asian Pac J Cancer Prev. 2012;13:41–45. - PubMed
    1. Boonjaraspinyo S, Wu Z, Boonmars T, Kaewkes S, et al. Overexpression of PDGFA and its receptor during carcinogenesis of Opisthorchis viverrini-associated cholangiocarcinoma. Parasitol Int. 2012;61:145–150. doi: 10.1016/j.parint.2011.07.008. - DOI - PubMed
    1. Buranrat B, Chau-in S, Prawan A, et al. NQO1 Expression Correlates with Cholangiocarcinoma Prognosis. Asian Pac J Cancer Prev. 2012;13:131–136. - PubMed

LinkOut - more resources